Drawing for TEMSO

USPTO serial 78642068

TEMSO

Reviewed by CopyMark Law Group

Reg. 3249005Status 710
Filing date
Status date
Registration date
Jun 5, 2007
Examiner
KIM, YONG OH
Law office
—

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TEMSO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Upton Douglass

Susan Upton Douglass Fross Zelnick Lehrman & Zissu, P.C.4 TIMES SQUARE, 17TH FLOORNew York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
016[ publications, namely, journals, magazines, periodicals and brochures related to the medical or pharmaceutical fields, and printed instructional and teaching materials in the medical and pharmaceutical fields ]SECTION 8 - CANCELLED—
041[ educational services, namely, organizing and conducting colloquiums, conferences, and congresses concerning pharmaceutical or medical products and information related thereto; conducting training, workshops and courses in pharmaceutical advertising; and the distribution of printed and electronic course materials in connection with all of the aforementioned educational services ]SECTION 8 - CANCELLED—
042scientific research in the nature of conducting clinical trials and scientific experimentation concerning pharmaceuticalsSECTION 8 - CANCELLED—
044[ providing medical information relative to pharmaceutical products via the Internet and intranet; providing an on-line computer database in the field of pharmaceuticals and medicine ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 12, 2018CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Apr 5, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2016REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 7, 2013NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 7, 2013C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 6, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 17, 2013815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
May 17, 2013E815TEAS SECTION 8 & 15 RECEIVED—
Mar 7, 2012CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 7, 2012COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 1, 2011ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 5, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 5, 2007DOCKASSIGNED TO EXAMINER—
Mar 20, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2007NPUBNOTICE OF PUBLICATION—
Jan 26, 2007ADBS1(B) BASIS DELETED; NEW BASIS REQUESTED—
Jan 18, 2007PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Dec 21, 2006APETASSIGNED TO PETITION STAFF—
Dec 15, 2006IUCNNOTICE OF ALLOWANCE CANCELLED—
Dec 15, 2006PDCBPETITION TO DIRECTOR - CHANGE BASIS - RECEIVED—
Dec 15, 2006MAILPAPER RECEIVED—
Nov 21, 2006NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 29, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 9, 2006NPUBNOTICE OF PUBLICATION—
Jul 10, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 30, 2006ALIEASSIGNED TO LIE—
Jun 25, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 25, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 16, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 16, 2006MAILPAPER RECEIVED—
Dec 28, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2005DOCKASSIGNED TO EXAMINER—
Jun 8, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance